In the USPTO, claims may be rejected for a number of reasons. Being aware of the requirements of four sections of Title 35 of the United States Code allows companies to know what to expect during the patent process and how to overcome rejections.
In this white paper, Dave Splett, vice president of business development, Injectech, a medical component manufacturer, shares his insight into the current situation.
A study into the costs versus benefits of introducing 3D printing technology into hospitals has shown that such innovations aid complicated surgeries and can be a key tool in easing time and financial pressures for hospitals.
Nigel Flowers, UK managing director of Sumitomo (SHI) Demag explores the impact the pandemic has had on injection moulding investments, including robotics.
MedTech Europe warns that until challenges are resolved, roadblocks will continue to limit the sector’s ability to seamlessly supply certified devices under the new rules.
The coronavirus pandemic has seen a surge in demand for medical gloves … and a corresponding increase in PPE waste. Vinisha Joshi of Global Market Insights outlines the trends shaping the medical gloves market.
Ole Grøndahl Hansen, project manager, PVCMed Alliance, explores whether the healthcare community should look to reuse or recycle plastic medical waste.
Audrey Turley, senior biocompatibility expert at Nelson Labs, explains the value for medical device manufacturers to understand ISO 10993-23 and how to navigate the transition from in vivo irritation testing to in vitro testing.
Thomas Davison-Sebry, chief sustainability officer at Thermal Compaction Group, shares how their innovative device can help to resolve the global PPE waste problem.
Christoph Lhota, vice president, ENGEL medical explains how digital service products, such as remote maintenance and online support, are shifting into the focus because they have become key to ensuring productivity and delivery capability.
Didier Perret, medical business development manager, Branson Welding and Assembly at Emerson, considers medical device assembly scale-ups to meet market demands amid COVID-19.